Earnings Call · Q1 FY2025·2025-05-01

Q1 25EPS +18.95%·Rev n/aQ4 24EPS +24.56%·Rev n/aQ3 24EPS +5.77%·Rev n/aQ2 24EPS +60.00%·Rev n/a⚠ consensus missing

BIOMARIN PHARMACEUTICAL INC BMRN

Traci McCarty — Investor Relations

Alexander Hardy — Chief Executive Officer

Brian Mueller — Chief Financial Officer

Cristin Hubbard — Chief Commercial Officer

Greg Friberg — Chief Medical Officer

−1.1%1d on move date−2.6% vs SPY3d−4.9%5d−4.6%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BMRN calls or request research access.

More BMRN calls Browse calls Request research access